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The GenoType Mycobacterium assay was used to identify 98 mycobacteria isolates by using liquid cultures
from positive BACTEC, MGIT, and ESP bottles. This system identifies 16 mycobacteria. There was complete
agreement between the GenoType results and the laboratory identifications for Mycobacterium tuberculosis
complex and other Mycobacterium spp. GenoType also identified mixed mycobacterial infections.
While Mycobacterium tuberculosis complex strains are still
responsible for the majority of mycobacterium infections
worldwide, opportunistic infections caused by mycobacteria
other than M. tuberculosis have increased, mainly as a conse-
quence of several factors such as the AIDS epidemic (2). The
use of culture in liquid media in clinical mycobacteriology
laboratories improves the ability to detect growth of Mycobac-
terium spp. (11). Identification of a mycobacterium growing on
solid medium can be done by biochemical methods, such as
thin-layer chromatography (5), gas-liquid chromatography
(16), high-performance liquid chromatography (HPLC), DNA
probes, or direct sequencing (3, 13, 15). Reverse hybridization
assays can be performed directly from liquid culture for rapid
identification of M. tuberculosis complex (9). Unfortunately,
these tests only detect a limited number of mycobacteria spe-
cies of clinical significance other than M. tuberculosis.
The GenoType assay (Hain Diagnostika, Nehren, Germany)
allows for the identification of 16 different mycobacterial spe-
cies that are most frequently isolated in the clinical laboratory.
Isolation is commonly done by PCR amplification of the 16S-
23S ribosomal DNA spacer region followed by hybridization of
the biotinylated amplified DNA products with 16 specific oli-
gonucleotide probes. The specific probes are immobilized as
parallel lines on a membrane strip (1). The goal of this study
was to evaluate the GenoType assay for the identification and
differentiation of specific mycobacteria species directly from
positive liquid cultures, an approach not previously published
for this assay.
The GenoType assay was evaluated for specificity and speed
of the procedure in a routine clinical laboratory. Ninety-eight
clinical specimens from different patients were submitted for
culture, decontaminated with an equal volume of N-acetyl cys-
teine–4% NaOH, and concentrated by centrifugation. The sed-
iment was used to inoculate Middlebrook 7H11 agar,
BACTEC 12B broth, MGIT broth, and ESPII Myco broth.
The cultures were incubated at 37°C for 6 weeks according to
the manufacturer’s instructions. When a BACTEC culture had
a growth index (GI) of 100, it was visibly positive by Ziehl-
Neelsen stain. In MGIT the microscopy was positive from 100
growth units (GU), and in ESPII the microscopy was positive
the same day as the culture was identified as positive by the
ESP instrument. In those positive cultures with values lower
than the ones mentioned, results with the stain were negative
and the absence of contamination was confirmed.
Positive cultures were identified by DNA probes (Accu-
probe; Gen-Probe, Inc.), conventional biochemical tests per-
formed according to standard protocols, and HPLC (6, 10, 12).
For identification with the GenoType assay, we used all posi-
tive cultures from Middlebrook 7H11 agar, MGIT positives
bottles with 135 GU, BACTEC positive bottles with a GI of
30, and ESPII positive bottles on the same day that they were
detected as positive.
The initial procedure for solid medium was to dilute a small
amount of colonies with 1.0 ml of TE buffer (10 nM Tris-HCl
[pH 8.0], 1 nm EDTA). For liquid media, 1 to 2 ml was
centrifuged at 3,000  g for 5 min, the supernatant was dis-
carded, and the pellet was diluted with 1.0 ml of TE buffer. All
test samples were boiled at 95°C for 15 min in order to extract
DNA. Amplification was performed as follows: 5 l of ex-
tracted DNA was added to 45.5 l of reagent mix, which
consisted of 35 l of primer-nucleotide mix, 5 l of amplifica-
tion buffer, 5 l of MgCl2, and 0.5 l of Taq polymerase. The
amplification mix was placed into a Perkin Elmer 9600 thermal
cycler and run for 1 cycle at 95°C for 15 min, 10 cycles at 95°C
for 30 s and 60°C for 2 min, 20 cycles at 55°C for 3 s and 72°C
for 3 s, and 1 cycle at 72°C for 8 min. The detection of the
amplified products was performed on agarose gel.
For the hybridization step, a 50°C shaking water bath and a
tray for strips were required. A volume of 20 l of the ampli-
fied product was mixed carefully with 20 l of denaturation
solution and incubated for 5 min at room temperature. One
milliliter of the hybridization buffer was added to the strips
with the immobilized probes and incubated for 30 min in a
50°C shaking water bath, followed by washing twice in 1.0 ml
with stringent wash solution for 1 min. This step was followed
by incubation in 1.0 ml of the stringent solution for 15 min in
the 50°C shaking water bath and by washing twice using Rinse
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I solution (GenoType; Hain Diagnostika). One milliliter of
diluted conjugate (1:100 in conjugate buffer) was added and
incubated for 30 min on a shaking platform at room temper-
ature. The conjugate was removed and the strips were washed
three times with 1.0 ml of Rinse II solution. It was then aspi-
rated and 1.0 ml of substrate was added. The sample was then
incubated for 10 to 15 min in the dark without shaking. The
color development was stopped by rinsing the strips twice with
distilled water. The strips were transferred to a paper towel for
drying. Once the strips were completely dry, the results were
interpreted using the reading card provided by the manufac-
turer (Hain Diagnostika). Positive bands corresponded to dif-
ferent Mycobacterium species. In order to identify mixed infec-
tions, mycobacteria cultured on Middlebrook 7H11 were
incubated at 28, 37, and 40°C for 60 days. Positive cultures
were assessed microscopically. When more than one mycobac-
terial colony was present, each type was characterized using
biochemical and genetic procedures or liquid chromatography
(HPLC) (8).
All positive cultures were tested in the GenoType assay from
both solid medium and all of the liquid media.
The GenoType assay identified 93 mycobacteria isolates at
species level and 5 at genus level. There was agreement be-
tween the GenoType assay results and the laboratory identifi-
cation tests for the following isolates: 47 M. tuberculosis com-
plex, 8 M. avium, 2 M. intracellulare, 2 M. kansasii, 8 M.
gordonae, 4 M. fortuitum, 6 M. chelonae, 6 M. peregrinum, 4 M.
marinum, and 2 M. xenopi (Table 1). In two clinical samples,
bands were present for both M. tuberculosis and M. fortuitum.
Results from the 7H11 agar plates confirmed the presence of
two mycobacteria strains. The same results were observed in
one case each of M. tuberculosis with M. avium and M. tuber-
culosis with M. kansasii.
There were 2 isolates of M. interjectum, 2 M. diernohferi
isolates, and 1 M. gadium isolate that were identified to only
the genus level. The GenoType assay does not include species-
specific probes for these organisms.
Of the 98 total samples, smears were positive in 45 and
negative in 53 samples. All samples were identified by the
GenoType assay and cultured on Middlebrook agar. The
BACTEC GI for M. tuberculosis was 100 for 16 of 47 strains;
for 11 strains, the GI was between 100 and 500; for 7 strains,
the GI was between 500 and 900; and for 13 strains, the GI was
999. For other mycobacteria the results were as follows: for
eight isolates of M. avium the growth index was 184; for two
isolates of M. intracellulare, the GIs were 230 and 250; for two
isolates of M. kansasii, the GIs were 214 and 58; for seven of
eight isolates of M. gordonae, the GI was 999, and for one of
these eight isolates the GI was 630; for four isolates of
M. fortuitum, the GI was less than 100; for M. chelonae and M.
peregrinum, the GI was less than 215. For M. marinum, M.
xenopi, and the other coexistent strains, the GI was 999. Over-
all for the BACTEC 460 system, 25 isolates were identified
with a GI of less than 100, 20 isolates had a GI between 100
and 500, and 40 isolates had a GI of greater than 500. Using
the MGIT system, of the 47 positive isolates identified as M.
tuberculosis, 18 isolates had a GU of 1,000, 14 isolates had a
GU of 1,000 to 2,000, 10 isolates had a GU of 2,000 to 4,000,
and 5 isolates had a GU of 2,000. For the other mycobacte-
rial isolates, 22 had a GU of 1,000, 3 had a GU between 1,001
and 2,000, 12 isolates had a GU of 2,001 to 4,000, and 12
isolates had a GU of 4,000. On the ESPII system, 12 M.
tuberculosis isolates were identified between 5 and 7 days, 16
were identified between 7 and 10 days, and 19 were identified
between 10 and 15 days. For the other mycobacterial isolates,
the identification required the following time: 5 to 7 days for 23
isolates, 8 to 10 days for 6 isolates, and 11 to 16 days for 17
isolates.
The GenoType assay was laborious to perform, but the in-
terpretation of the results was clear and easy. DNA probe tests
are more rapid than the GenoType assay and require only the
extraction and hybridization step with little manipulation. The
GenoType assay requires extraction, amplification, and hybrid-
ization, which require more labor. The main advantage of the
GenoType assay over GeneProbe DNA probes and LiPA as-
says is that the GenoType assay can identify a wider range of
species in a single assay, which eliminates the need to perform
different tests for each species or the wait for growth on solid
medium to guide the identification algorithm. DNA probe tests
do not identify mixed infections containing different Mycobac-
teria strains in a single analysis, which can give false results if
other assays are not performed in conjunction with the probe
tests. The GenoType assay identifies coinfections by different
mycobacteria, which can result in greater clinical relevance. (4,
7, 14, 17).
According to kit costs, the price for detection by the Geno-
Type assay is about 95 to 100 Euros. The price is similar to
GenProbe’s test, which contains only four identification
probes, compared to the GenoType assay which can identify 16
mycobacteria strains and coinfections by different mycobacte-
rial species. However, one single test from Gen Probe is less
expensive (23 Euros). A disadvantage of the restriction frag-
ment length polymorphism method is that it requires more
technical expertise in order to obtain a correct interpretation
of results than the GenoType assay. A disadvantage of HPLC
is that a larger quantity of culture is required in order to
perform the identification.
TABLE 1. Summary of mycobacterial species identification by all
methods tested
Organism No. ofisolates
No. of isolates positive by:




M. avium 8 8 8
M. intracellulare 2 2 2
M. kansasii 2 2 2
M. gordonae 8 8 8
M. fortuitum 4 4 4 4
M. chelonae 6 6 6 6
M. peregrinum 6 6 6 6
M. marinum 4 4 4 4
M. xenopi 2 2 2 2
M. interjectum 2 2 2
M. diernohferi 2 2 2
M. gadium 1 1 1
MTB  M. fortuitum 2 2 2 2
MTB  M. avium 1 1 1 1
MTB  M. kansasii 1 1 1 1
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In our laboratory, 48% of mycobacterial isolates were M.
tuberculosis complex as identified by DNA probes. Addition-
ally, 8.1% of the isolates were identified as M. avium, 2.0% as
M. intracellulare, 2.0% as M. kansasii, and 8.1% as M. gordonae
using DNA probes. The GenoType assay was able to identify
these isolates directly from the positive BACTEC 12B, MGIT,
and ESPII broths with a single assay. The assay could also
identify M. fortuitum, M. chelonae, M. peregrinum, M. marinum,
and M. xenopi, which comprised 4.08, 6.1, 6.1, 4.08, and 2.04%
of the isolates, respectively. Overall, the GenoType assay cor-
rectly identified 94.9% of all isolates in our laboratory to the
species level. The remaining 3.1% of isolates are miscellaneous
organisms such as M. interjectum, M. diernohferi, and M. ga-
dium, for which the GenoType assay does not have a species-
specific probe. With these results, we validated the system for
species identification from cultured material in the BACTEC
system with a GI of 30, in MGIT with a GU of 135, and in
ESPII after 5 days of incubation. The data include samples that
were acid-fast bacillus smear negative.
Prior to this study, the GenoType assay had been tested only
on ATCC strains grown on solid media. In this study we have
validated the performance of the assay directly from positive
BACTEC, MGIT, and ESPII liquid media for the following
isolates: M. avium, M. celatum, M. chelonae, M. fortuitum 1, M.
fortuitum 2, M. gordonae, M. intracellulare, M. kansasii, M. mal-
moense, M. peregrinum, M. phlei, M. scrofulaceum, M. tubercu-
losis complex, M. avium complex, M. marinum, and M. xenopi.
In conclusion, we found the GenoType assay to be an easy-
to-interpret and rapid test to perform in the clinical setting.
The advantages of the test are that (i) it provides identification
of a large variety of mycobacterial species in a single test and
(ii) it can identify multiple mycobacterial species within the
same sample.
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